Tag Archives: DNA

Outsmarting HIV with X-Ray Crystallography

Dr, Alian Akram, Lorry I. Lokey Center for Life Science & Engineering, Technion.

Outsmarting HIV


It sound like modern warfare, and indeed, even when aiming to outsmart a killer virus on a scale of about 100 nanometers, the latest technology makes all the difference. One of the deep passions behind Dr. Alian Akram’s pioneering crystallographic work in the Technion is a desire to advance treatments for HIV, the causative agent of AIDS.



Scientists in Akram’s lab investigate the general principles of how aggressive virus lock into the genetic resources of a patient – and how to prevent them from doing this. “It is a MUST to learn about the critical interactions and the mechanisms of resistance,” says Akram. The team is taking a sharp look at pathogen-host interaction and how the HIV virus literally hijacks the machinery of the host cell in order to replicate itself, and how it escapes the immune system. “We are hoping to determine the structures of key interacting molecules and develop new intervening strategies and drugs that prevent their interaction. We also want to understand the mechanism of emergent resistance in the proteins of this virus.”



Current drugs for HIV bind viral proteins – and yet it continues to mutate and regenerate. Akram’s team is working on a protein discovered in 2004 – intrinsic immunity APOBEC3G. This protein attacks the genome of HIV and causes hypermutation that leads to an abortive replication cycle for HIV. However, HIV expresses a protein that destroys APOBEC, so the Akram’s group wants to understand this process better so that it can be blocked.
Crystal structure of Pseudouridine synthase in complex with RNA solved by  Akram Alian. The structure reveals base-pair rearrangement as the key mechanism to rRNA substrate selectivity  (http://rnajournal.cshlp.org/content/16/6.cover-expansion)”

Outsmarting HIV with X-Ray Crystallography

Dr, Alian Akram, Lorry I. Lokey Center for Life Science & Engineering, Technion.

Outsmarting HIV


It sound like modern warfare, and indeed, even when aiming to outsmart a killer virus on a scale of about 100 nanometers, the latest technology makes all the difference. One of the deep passions behind Dr. Alian Akram’s pioneering crystallographic work in the Technion is a desire to advance treatments for HIV, the causative agent of AIDS.



Scientists in Akram’s lab investigate the general principles of how aggressive virus lock into the genetic resources of a patient – and how to prevent them from doing this. “It is a MUST to learn about the critical interactions and the mechanisms of resistance,” says Akram. The team is taking a sharp look at pathogen-host interaction and how the HIV virus literally hijacks the machinery of the host cell in order to replicate itself, and how it escapes the immune system. “We are hoping to determine the structures of key interacting molecules and develop new intervening strategies and drugs that prevent their interaction. We also want to understand the mechanism of emergent resistance in the proteins of this virus.”



Current drugs for HIV bind viral proteins – and yet it continues to mutate and regenerate. Akram’s team is working on a protein discovered in 2004 – intrinsic immunity APOBEC3G. This protein attacks the genome of HIV and causes hypermutation that leads to an abortive replication cycle for HIV. However, HIV expresses a protein that destroys APOBEC, so the Akram’s group wants to understand this process better so that it can be blocked.
Crystal structure of Pseudouridine synthase in complex with RNA solved by  Akram Alian. The structure reveals base-pair rearrangement as the key mechanism to rRNA substrate selectivity  (http://rnajournal.cshlp.org/content/16/6.cover-expansion)”

Technion researchers successfully build “a biological Rosetta Stone” inside a bacterium

Technion researchers successfully build “a biological Rosetta Stone” inside a bacterium

“Now we can understand, at least partially, many natural programs that have not yet been decoded by simply reading the DNA sequence.”
Technion researchers successfully build “a biological Rosetta Stone” inside a bacterium. They hope that in the future this will enable the translation of the genome’s “operating system”; they are working in the new field of synthetic biology and believe that this will be “the high tech of bio tech”.
The prestigious science journal, Cell, reports that Technion researchers in collaboration with Caltech researchers have successfully built a “biological Rosetta Stone” within a bacterium, by developing a new understanding of the group of bacterial regulators called Enhancers. These objects encompass non-gene coding sequences on DNA, to which proteins attach. These objects function by integrating several proteins, and upon reaching the correct combination, the target gene is expressed. By learning how to “program” these enhancer, the researchers hope to gain a more precise control of gene expression.

“One of the central discoveries in biology in the post-genome era is the understanding that the main factors contributing to the differences between organisms (for instance, between mice and men) is not the result of genes,” explains Dr. Roee Amit of the Faculty of Biotechnology and Food Engineering at the Technion, who began his research as part of a post-doctoral fellowship at Caltech. “The origin of this difference is in the algorithm or program that determines when, where and how any gene will be expressed. In the past few years a new picture of the genome is becoming clearer, and as a result, also a model in which the genome is perceived as a complex tool for storage and dissemination of information.”

The objective of the Technion researchers is to decode the “software” that controls the process and use this knowledge to develop medical applications. “In order to do this, we intend to create a ‘Rosetta Stone’ for the gene regulatory code (the original Rosetta Stone is a granodiorite stele that had the same ancient text inscribed on it in three different languages, as a result of which archaeologists were able to decipher Egyptian hieroglyphics),” says Dr. Amit.

“This tool will be used to ‘hack’ the control program of real organisms and consequently allow us to ‘write’ new programs – which do not exist in nature – for medical purposes, environmental applications, etc. Synthetic biology is a new branch of life science, which takes a constructive/building approach. It attempts to use biological components to construct new biological systems that do not exist in nature. It forces us to really examine our understanding by requiring us to use what we think we understand in order to create biological functions. It allows us to ask why evolution “locked onto” specific patterns, to imagine and create new biological functions and forces us to work in a multidisciplinary fashion.”

The approach of researchers in synthetic biology is based on using characteristic genomic components and arranging them together (or “wiring” them to each other) in new architectures. In the next stage they develop patterns based on thermodynamic models, and in the end, they analyze the output using their model. By doing this, they can draw basic programming principles that permit them to translate the architecture and the sequence into computer algorithms. “If we succeed in writing a sequence that predicts our output based on computerized rules that we found in the ‘Rosetta Stone’ – we can then use this ‘key’ to decipher certain sequences that appear in the genome,” says Dr. Amit.
In the paper appearing in Cell, the Technion researchers show that they can use this approach to develop a new understanding of enhancers among bacteria. These sequences are common to all living creatures and may be thought of as modular objects that can combine “input” or signals. Because bacterial enhancers have a simpler architecture and at times it is easier to characterize them, the Technion researchers chose to focus on them first. The researches demonstrated the possibility of building new bacterial enhancer programs that will lead to a physical model of the control program, or to the “machine code”. The researchers note that the type of computerization that takes place in this context is reminiscent of analogue computing processes more than digital ones.
“This Rosetta Stone, in the bacterial context, has enabled us to formulate a new understanding, or qualitative model, for many examples of bacterial enhancers in nature, most of which have never been analyzed,” stresses Dr. Amit. “Now we can understand, at least partially, many natural programs that have not yet been decoded by simply reading the DNA sequence.”

Technion researchers successfully build “a biological Rosetta Stone” inside a bacterium

Technion researchers successfully build “a biological Rosetta Stone” inside a bacterium

“Now we can understand, at least partially, many natural programs that have not yet been decoded by simply reading the DNA sequence.”
Technion researchers successfully build “a biological Rosetta Stone” inside a bacterium. They hope that in the future this will enable the translation of the genome’s “operating system”; they are working in the new field of synthetic biology and believe that this will be “the high tech of bio tech”.
The prestigious science journal, Cell, reports that Technion researchers in collaboration with Caltech researchers have successfully built a “biological Rosetta Stone” within a bacterium, by developing a new understanding of the group of bacterial regulators called Enhancers. These objects encompass non-gene coding sequences on DNA, to which proteins attach. These objects function by integrating several proteins, and upon reaching the correct combination, the target gene is expressed. By learning how to “program” these enhancer, the researchers hope to gain a more precise control of gene expression.

“One of the central discoveries in biology in the post-genome era is the understanding that the main factors contributing to the differences between organisms (for instance, between mice and men) is not the result of genes,” explains Dr. Roee Amit of the Faculty of Biotechnology and Food Engineering at the Technion, who began his research as part of a post-doctoral fellowship at Caltech. “The origin of this difference is in the algorithm or program that determines when, where and how any gene will be expressed. In the past few years a new picture of the genome is becoming clearer, and as a result, also a model in which the genome is perceived as a complex tool for storage and dissemination of information.”

The objective of the Technion researchers is to decode the “software” that controls the process and use this knowledge to develop medical applications. “In order to do this, we intend to create a ‘Rosetta Stone’ for the gene regulatory code (the original Rosetta Stone is a granodiorite stele that had the same ancient text inscribed on it in three different languages, as a result of which archaeologists were able to decipher Egyptian hieroglyphics),” says Dr. Amit.

“This tool will be used to ‘hack’ the control program of real organisms and consequently allow us to ‘write’ new programs – which do not exist in nature – for medical purposes, environmental applications, etc. Synthetic biology is a new branch of life science, which takes a constructive/building approach. It attempts to use biological components to construct new biological systems that do not exist in nature. It forces us to really examine our understanding by requiring us to use what we think we understand in order to create biological functions. It allows us to ask why evolution “locked onto” specific patterns, to imagine and create new biological functions and forces us to work in a multidisciplinary fashion.”

The approach of researchers in synthetic biology is based on using characteristic genomic components and arranging them together (or “wiring” them to each other) in new architectures. In the next stage they develop patterns based on thermodynamic models, and in the end, they analyze the output using their model. By doing this, they can draw basic programming principles that permit them to translate the architecture and the sequence into computer algorithms. “If we succeed in writing a sequence that predicts our output based on computerized rules that we found in the ‘Rosetta Stone’ – we can then use this ‘key’ to decipher certain sequences that appear in the genome,” says Dr. Amit.
In the paper appearing in Cell, the Technion researchers show that they can use this approach to develop a new understanding of enhancers among bacteria. These sequences are common to all living creatures and may be thought of as modular objects that can combine “input” or signals. Because bacterial enhancers have a simpler architecture and at times it is easier to characterize them, the Technion researchers chose to focus on them first. The researches demonstrated the possibility of building new bacterial enhancer programs that will lead to a physical model of the control program, or to the “machine code”. The researchers note that the type of computerization that takes place in this context is reminiscent of analogue computing processes more than digital ones.
“This Rosetta Stone, in the bacterial context, has enabled us to formulate a new understanding, or qualitative model, for many examples of bacterial enhancers in nature, most of which have never been analyzed,” stresses Dr. Amit. “Now we can understand, at least partially, many natural programs that have not yet been decoded by simply reading the DNA sequence.”